Clinical Trials
6 trialsNCT07561775 2026-05-01
Adebrelimab Plus S-1 for Resected Cholangiocarcinoma
Tongji Hospital
Phase 2 Not yet recruiting
NCT06901622 2025-03-30
Camrelizumab and Chemotherapy With or Without Anlotinib as First-line Treatment for Advanced Gallbladder Cancer and Extrahepatic Cholangiocarcinoma
The First Affiliated Hospital of Zhengzhou University
Phase 2 Enrolling by invitation
NCT06903273 2025-03-30
TisGCS for BTC
National Cheng-Kung University Hospital
Phase 2 Not yet recruiting
NCT04856761 2022-08-18
A Study of Capecitabine Versus S-1 as Adjuvant Therapy in Patients With Biliary Tract Carcinoma After Surgical Resection
Fudan University
Unknown
NCT02592538 2019-11-19
Endobiliary Radiofrequency Ablation With S-1 for Unresectable Cholangiocarcinoma
First People's Hospital of Hangzhou
Phase NA Completed
NCT01963325 2018-02-05
S-1 in Combination With Abraxane in Treating Cholangiocarcinoma
Sun Yat-sen University
Phase 2 Completed